Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asset Pharma is an Italian pharmaceutical company focused on the development and commercialization of innovative therapeutic solutions, primarily in the fields of nutraceuticals and medical devices. The company specializes in several therapeutic areas including gastroenterology, urology, gynecology, and pediatrics, offering a range of products designed to improve patient quality of life. Asset Pharma emphasizes research and development to create high-quality formulations that meet specific clinical needs. Their business model involves both direct commercialization in the Italian market and strategic partnerships for broader distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on assets.